![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
CF Bennett, MY Chiang, H Chan, JE Shoemaker and CK Mirabelli
Department of Molecular and Cellular Biology, ISIS Pharmaceuticals, Carlsbad, California 92008.
We have investigated the use of a cationic lipid preparation to enhance antisense oligonucleotide activity in human umbilical vein endothelial cells. A liposomal preparation containing the cationic lipid N-[1-(2,3- dioleyloxy)propyl]-N,N,N-trimethylammonium chloride (DOTMA) was found to increase by at least 1000-fold the potency of an antisense oligonucleotide (ISIS 1570) that hybridizes to the AUG translation initiation codon of human intercellular adhesion molecule-1. In the presence of 8 microM DOTMA, 6-15-fold more 35S-ISIS 1570 associated with cells, at oligonucleotide concentrations from 0.01 to 5 microM, than did in the absence of DOTMA. Both 35S-ISIS 1570 association with cells and antisense activity were increased as a function of DOTMA concentration and with increasing time of incubation with the cationic lipid. Fluorescein-labeled ISIS 1570 was used to assess the intracellular distribution of the oligonucleotide in the presence and absence of DOTMA. In the absence of DOTMA, the oligonucleotide localized to discrete structures in the cytoplasm of the cell, resulting in a punctate fluorescence pattern. In the presence of DOTMA, cellular fluorescence markedly increased and the oligonucleotide localized within the nucleus, as well as to discrete structures in the cytoplasm. Accumulation of the oligonucleotide in the nucleus in the presence of DOTMA was time and temperature dependent. Nuclear accumulation was inhibited by preincubation of the cells with monensin but not chloroquine, NH4Cl, nocodazole, colcemid, or brefeldin A. These data demonstrate that cationic lipids increase antisense activity by increasing the amount of oligonucleotide associated with cells and altering intracellular distribution of the oligonucleotide.
This article has been cited by other articles:
|
|
 |
|
  S. Hussain, A. Pluckthun, T. M. Allen, and U. Zangemeister-Wittke Chemosensitization of carcinoma cells using epithelial cell adhesion molecule-targeted liposomal antisense against bcl-2/bcl-xL Mol. Cancer Ther., December 1, 2006; 5(12): 3170 - 3180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Watanabe, H. Sawai, I. Ogihara-Umeda, S. Tanada, E. E. Kim, Y. Yonekura, and Y. Sasaki Molecular Therapy of Human Neuroblastoma Cells Using Auger Electrons of 111In-Labeled N-myc Antisense Oligonucleotides J. Nucl. Med., October 1, 2006; 47(10): 1670 - 1677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. A. Efimov, K. R. Birikh, D. B. Staroverov, S. A. Lukyanov, M. B. Tereshina, A. G. Zaraisky, and O. G. Chakhmakhcheva Hydroxyproline-based DNA mimics provide an efficient gene silencing in vitro and in vivo. Nucleic Acids Res., January 1, 2006; 34(8): 2247 - 2257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Turner, G. D. Ivanova, B. Verbeure, D. Williams, A. A. Arzumanov, S. Abes, B. Lebleu, and M. J. Gait Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells Nucleic Acids Res., November 30, 2005; 33(21): 6837 - 6849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Turner, A. A. Arzumanov, and M. J. Gait Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides Nucleic Acids Res., January 7, 2005; 33(1): 27 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Drygin, S. Barone, and C. F. Bennett Sequence-dependent cytotoxicity of second-generation oligonucleotides Nucleic Acids Res., December 16, 2004; 32(22): 6585 - 6594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Reuben, Y. Sun, and H. S. Cheung Basic Calcium Phosphate Crystals Activate p44/42 MAPK Signal Transduction Pathway via Protein Kinase C{micro} in Human Fibroblasts J. Biol. Chem., August 20, 2004; 279(34): 35719 - 35725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Weisman, D. Hirsch-Lerner, Y. Barenholz, and Y. Talmon Nanostructure of Cationic Lipid-Oligonucleotide Complexes Biophys. J., July 1, 2004; 87(1): 609 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Urban, T. Golden, I. V. Aragon, L. Cowsert, S. R. Cooper, N. M. Dean, and R. E. Honkanen Identification of a Functional Link for the p53 Tumor Suppressor Protein in Dexamethasone-induced Growth Suppression J. Biol. Chem., March 7, 2003; 278(11): 9747 - 9753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ye, L. Wang, X. Zhang, V. Tantishaiyakul, and Y. Rojanasakul Inhibition of TNF-alpha gene expression and bioactivity by site-specific transcription factor-binding oligonucleotides Am J Physiol Lung Cell Mol Physiol, February 1, 2003; 284(2): L386 - L394. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kerkela, M. Ilves, S. Pikkarainen, H. Tokola, J. Ronkainen, O. Vuolteenaho, J. Leppaluoto, and H. Ruskoaho Identification of PKCalpha Isoform-Specific Effects in Cardiac Myocytes Using Antisense Phosphorothioate Oligonucleotides Mol. Pharmacol., December 1, 2002; 62(6): 1482 - 1491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kim, N. Suh, M. Sporn, and J. C. Reed An Inducible Pathway for Degradation of FLIP Protein Sensitizes Tumor Cells to TRAIL-induced Apoptosis J. Biol. Chem., June 14, 2002; 277(25): 22320 - 22329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Fisher, D. Ye, D. S. Sergueev, M. H. Fisher, B. R. Shaw, and R. L. Juliano Evaluating the Specificity of Antisense Oligonucleotide Conjugates. A DNA ARRAY ANALYSIS J. Biol. Chem., June 14, 2002; 277(25): 22980 - 22984. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. R. Smythe, I. Mohuiddin, M. Ozveran, and X. X. Cao Antisense therapy for malignant mesothelioma with oligonucleotides targeting the bcl-xl gene product J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1191 - 1198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. S. Zuhorn, R. Kalicharan, and D. Hoekstra Lipoplex-mediated Transfection of Mammalian Cells Occurs through the Cholesterol-dependent Clathrin-mediated Pathway of Endocytosis J. Biol. Chem., May 10, 2002; 277(20): 18021 - 18028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Dias and C. A. Stein Antisense Oligonucleotides: Basic Concepts and Mechanisms Mol. Cancer Ther., March 1, 2002; 1(5): 347 - 355. [Full Text] [PDF]
|
|
|
|
 |
|
 I. T. R. Cavarretta, R. Mukopadhyay, D. M. Lonard, L. M. Cowsert, C. F. Bennett, B. W. O'Malley, and C. L. Smith Reduction of Coactivator Expression by Antisense Oligodeoxynucleotides Inhibits ER{alpha} Transcriptional Activity and MCF-7 Proliferation Mol. Endocrinol., February 1, 2002; 16(2): 253 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. ROMANO, A. CATALANO, M. NUTINI, E. D'URBANO, C. CRESCENZI, J. CLARIA, R. LIBNER, G. DAVI, and A. PROCOPIO 5-Lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endothelial growth factor FASEB J, November 1, 2001; 15(13): 2326 - 2336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sazani, S.-H. Kang, M. A. Maier, C. Wei, J. Dillman, J. Summerton, M. Manoharan, and R. Kole Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs Nucleic Acids Res., October 1, 2001; 29(19): 3965 - 3974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Hauck, D. J. Sieg, D. A. Hsia, J. C. Loftus, W. A. Gaarde, B. P. Monia, and D. D. Schlaepfer Inhibition of Focal Adhesion Kinase Expression or Activity Disrupts Epidermal Growth Factor-stimulated Signaling Promoting the Migration of Invasive Human Carcinoma Cells Cancer Res., October 1, 2001; 61(19): 7079 - 7090. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Catalano, M. Romano, I. Robuffo, L. Strizzi, and A. Procopio Methionine Aminopeptidase-2 Regulates Human Mesothelioma Cell Survival : Role of Bcl-2 Expression and Telomerase Activity Am. J. Pathol., August 1, 2001; 159(2): 721 - 731. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Malaga and N. Yoshida Targeted Reduction in Expression of Trypanosoma cruzi Surface Glycoprotein gp90 Increases Parasite Infectivity Infect. Immun., January 1, 2001; 69(1): 353 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yoo and R. L. Juliano Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers Nucleic Acids Res., November 1, 2000; 28(21): 4225 - 4231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Keller, B. Schu, R. Rüdel, and H. Brinkmeier Cellular Uptake and Efficacy of Antisense Oligonucleotides against RNAs of Two Na+ Channel Isoforms J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 367 - 372. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Q. Sun, M. J. Cairns, E. G. Saravolac, A. Baker, and W. L. Gerlach Catalytic Nucleic Acids: From Lab to Applications Pharmacol. Rev., September 1, 2000; 52(3): 325 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-Y. Jen and A. M. Gewirtz Suppression of Gene Expression by Targeted Disruption of Messenger RNA: Available Options and Current Strategies Stem Cells, September 1, 2000; 18(5): 307 - 319. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. P. Claudio, M. Caputi, and A. Giordano The RB2/p130 Gene: The Latest Weapon in the War against Lung Cancer? Clin. Cancer Res., March 1, 2000; 6(3): 754 - 764. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Pagnan, D. D. Stuart, F. Pastorino, L. Raffaghello, P. G. Montaldo, T. M. Allen, B. Calabretta, and M. Ponzoni Delivery of c-myb Antisense Oligodeoxynucleotides to Human Neuroblastoma Cells Via Disialoganglioside GD2-Targeted Immunoliposomes: Antitumor Effects J Natl Cancer Inst, February 2, 2000; 92(3): 253 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Klimuk, S. C. Semple, P. N. Nahirney, M. C. Mullen, C. F. Bennett, P. Scherrer, and M. J. Hope Enhanced Anti-Inflammatory Activity of a Liposomal Intercellular Adhesion Molecule-1 Antisense Oligodeoxynucleotide in an Acute Model of Contact Hypersensitivity J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 480 - 488. [Abstract] [Full Text]
|
|
|
|
|
|
M. Butler, R. M. Crooke, M. J. Graham, K. M. Lemonidis, M. Lougheed, S. F. Murray, D. Witchell, U. Steinbrecher, and C. F. Bennett Phosphorothioate Oligodeoxynucleotides Distribute Similarly in Class A Scavenger Receptor Knockout and Wild-Type Mice J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 489 - 496. [Abstract] [Full Text]
|
|
|
|
|
|
A. Cheng, N. M. Dean, and R. E. Honkanen Serine/Threonine Protein Phosphatase Type 1gamma 1 Is Required for the Completion of Cytokinesis in Human A549 Lung Carcinoma Cells J. Biol. Chem., January 21, 2000; 275(3): 1846 - 1854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pichon, M. B. Roufai, M. Monsigny, and P. Midoux Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotides Nucleic Acids Res., January 15, 2000; 28(2): 504 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lorenz, T. Misteli, B. F. Baker, C. F. Bennett, and D. L. Spector Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides Nucleic Acids Res., January 15, 2000; 28(2): 582 - 592. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Zine, T. Van De Water, and F de Ribaupierre Notch signaling regulates the pattern of auditory hair cell differentiation in mammals Development, January 8, 2000; 127(15): 3373 - 3383. [Abstract] [PDF]
|
|
|
|
|
|
G. Romano, P. Micheli, C. Pacilio, and A. Giordano Latest Developments in Gene Transfer Technology: Achievements, Perspectives, and Controversies over Therapeutic Applications Stem Cells, January 1, 2000; 18(1): 19 - 39. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Liu, J. Ou, K. Saku, S. Jimi, D. P. Via, J. T. Sparrow, B. Zhang, H. J. Pownall, L. C. Smith, and K. Arakawa Efficient Nuclear Delivery of Antisense Oligodeoxynucleotides and Selective Inhibition of CETP Expression by Apo E Peptide in a Human CETP–Stably Transfected CHO Cell Line Arterioscler. Thromb. Vasc. Biol., September 1, 1999; 19(9): 2207 - 2213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. S. Santiago, D. G. Atkins, and L. M. Khachigian Vascular Smooth Muscle Cell Proliferation and Regrowth after Mechanical Injury in Vitro Are Egr-1/NGFI-A-Dependent Am. J. Pathol., September 1, 1999; 155(3): 897 - 905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Murakami, W. Ma, R. Fuleihan, and J. S. Pober Human Endothelial Cells Augment Early CD40 Ligand Expression in Activated CD4+ T Cells Through LFA-3-Mediated Stabilization of mRNA J. Immunol., September 1, 1999; 163(5): 2667 - 2673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Basilion, A. R. Schievella, E. Burns, P. Rioux, J. C. Olson, B. P. Monia, K. M. Lemonidis, V. P. Stanton Jr., and D. E. Housman Selective Killing of Cancer Cells Based on Loss of Heterozygosity and Normal Variation in the Human Genome: A New Paradigm for Anticancer Drug Therapy Mol. Pharmacol., August 1, 1999; 56(2): 359 - 369. [Abstract] [Full Text]
|
|
|
|
|
|
G. Schmajuk, H. Sierakowska, and R. Kole Antisense Oligonucleotides with Different Backbones. MODIFICATION OF SPLICING PATHWAYS AND EFFICACY OF UPTAKE J. Biol. Chem., July 30, 1999; 274(31): 21783 - 21789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Romano, C. Pacilio, and A. Giordano Gene Transfer Technology in Therapy: Current Applications and Future Goals Stem Cells, July 1, 1999; 17(4): 191 - 202. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. J. Mann, G. H. Gibbons, H. Hutchinson, R. S. Poston, E. G. Hoyt, R. C. Robbins, and V. J. Dzau Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues PNAS, May 25, 1999; 96(11): 6411 - 6416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Ackermann, J. K. Taylor, R. Narayana, and C. F. Bennett The Role of Antiapoptotic Bcl-2 Family Members in Endothelial Apoptosis Elucidated with Antisense Oligonucleotides J. Biol. Chem., April 16, 1999; 274(16): 11245 - 11252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bandyopadhyay, X. Ma, C. Linehan-Stieers, B. T. Kren, and C. J. Steer Nucleotide Exchange in Genomic DNA of Rat Hepatocytes Using RNA/DNA Oligonucleotides. TARGETED DELIVERY OF LIPOSOMES AND POLYETHYLENEIMINE TO THE ASIALOGLYCOPROTEIN RECEPTOR J. Biol. Chem., April 9, 1999; 274(15): 10163 - 10172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. S. Xu, C. Vanderziel, C. F. Bennett, and B. P. Monia A Role for c-Raf Kinase and Ha-Ras in Cytokine-mediated Induction of Cell Adhesion Molecules J. Biol. Chem., December 11, 1998; 273(50): 33230 - 33238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.-c. Tu, Q.-n. Cao, F. Zhou, and Y. Israel Tetranucleotide GGGA Motif in Primary RNA Transcripts. NOVEL TARGET SITE FOR ANTISENSE DESIGN J. Biol. Chem., September 25, 1998; 273(39): 25125 - 25131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Tomita, M. Horiuchi, S. Tomita, G. H. Gibbons, J. Y. S. Kim, D. Baran, and V. J. Dzau An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro Am J Physiol Renal Physiol, August 1, 1998; 275(2): F278 - F284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Romano, C. Pacilio, and A. Giordano Gene Transfer Technology in Therapy: Current Applications and Future Goals Oncologist, August 1, 1998; 3(4): 225 - 236. [Abstract] [Full Text]
|
|
|
|
|
|
R. William, G. Watson, O. D. Rotstein, J. Parodo, R. Bitar, and J. C. Marshall The IL-1{beta}-Converting Enzyme (Caspase-1) Inhibits Apoptosis of Inflammatory Neutrophils Through Activation of IL-1{beta} J. Immunol., July 15, 1998; 161(2): 957 - 962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Alahari, R. DeLong, M. H. Fisher, N. M. Dean, P. Viliet, and R. L. Juliano Novel Chemically Modified Oligonucleotides Provide Potent Inhibition of P-Glycoprotein Expression J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 419 - 428. [Abstract] [Full Text]
|
|
|
|
|
|
O. Meyer, D. Kirpotin, K. Hong, B. Sternberg, J. W. Park, M. C. Woodle, and D. Papahadjopoulos Cationic Liposomes Coated with Polyethylene Glycol As Carriers for Oligonucleotides J. Biol. Chem., June 19, 1998; 273(25): 15621 - 15627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Spiller, R. V. Giles, J. Grzybowski, D. M. Tidd, and R. E. Clark Improving the Intracellular Delivery and Molecular Efficacy of Antisense Oligonucleotides in Chronic Myeloid Leukemia Cells: A Comparison of Streptolysin-O Permeabilization, Electroporation, and Lipophilic Conjugation Blood, June 15, 1998; 91(12): 4738 - 4746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zuo, N. M. Dean, and R. E. Honkanen Serine/Threonine Protein Phosphatase Type 5 Acts Upstream of p53 to Regulate the Induction of p21WAF1/Cip1 and Mediate Growth Arrest J. Biol. Chem., May 15, 1998; 273(20): 12250 - 12258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Hartmann, A. Krug, M. Bidlingmaier, U. Hacker, A. Eigler, R. Albrecht, C. J. Strasburger, and S. Endres Spontaneous and Cationic Lipid-Mediated Uptake of Antisense Oligonucleotides in Human Monocytes and Lymphocytes J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 920 - 928. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Lorenz, B. F. Baker, C. F. Bennett, and D. L. Spector Phosphorothioate Antisense Oligonucleotides Induce the Formation of Nuclear Bodies Mol. Biol. Cell, May 1, 1998; 9(5): 1007 - 1023. [Abstract] [Full Text]
|
|
|
|
|
|
R. Kronenwett, U. Steidl, M. Kirsch, G. Sczakiel, and R. Haas Oligodeoxyribonucleotide Uptake in Primary Human Hematopoietic Cells Is Enhanced by Cationic Lipids and Depends on the Hematopoietic Cell Subset Blood, February 1, 1998; 91(3): 852 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Chen, S. Agrawal, W. Zhou, R. Zhang, and J. Chen Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage PNAS, January 6, 1998; 95(1): 195 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Schumacher, C. L. Cioffi, H. Sharif, W. Haston, B. P. Monia, and L. Wennogle Exposure of Human Vascular Smooth Muscle Cells to Raf-1 Antisense Oligodeoxynucleotides: Cellular Responses and Pharmacodynamic Implications Mol. Pharmacol., January 1, 1998; 53(1): 97 - 104. [Abstract] [Full Text]
|
|
|
|
|
|
I. Kitajima, N. Hanyu, Y. Soejima, R. Hirano, S. Arahira, S. Yamaoka, R. Yamada, I. Maruyama, and Y. Kaneda Efficient Transfer of Synthetic Ribozymes into Cells Using Hemagglutinating Virus of Japan (HVJ)-Cationic Liposomes. APPLICATION FOR RIBOZYMES THAT TARGET HUMAN T-CELL LEUKEMIA VIRUS TYPE I tax/rex mRNA J. Biol. Chem., October 24, 1997; 272(43): 27099 - 27106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Niidome, N. Ohmori, A. Ichinose, A. Wada, H. Mihara, T. Hirayama, and H. Aoyagi Binding of Cationic alpha -Helical Peptides to Plasmid DNA and Their Gene Transfer Abilities into Cells J. Biol. Chem., June 13, 1997; 272(24): 15307 - 15312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. F. Baker, S. S. Lot, T. P. Condon, S. Cheng-Flournoy, E. A. Lesnik, H. M. Sasmor, and C. F. Bennett 2'-O-(2-Methoxy)ethyl-modified Anti-intercellular Adhesion Molecule 1 (ICAM-1) Oligonucleotides Selectively Increase the ICAM-1 mRNA Level and Inhibit Formation of the ICAM-1 Translation Initiation Complex in Human Umbilical Vein Endothelial Cells J. Biol. Chem., May 2, 1997; 272(18): 11994 - 12000. [Abstract] [Full Text] |
